T2 Biosystems, Inc. (TTOO) Key Metrics
TTOO valuation today
Trailing 12 months · as of October 21, 2026- Market cap
- $19,631
- Enterprise value
- $16.9M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 0.0
- Price / book
- 14.5
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 8.18
TTOO key metrics, 2014–2023
Fiscal year ended December 31, 2023 · U.S. dollarsTTOO returns How much profit the business earns on the capital it uses.
Return on invested capital−147.7 pts
−534.1%
2023 · hover or tap a bar for each year
20142023
Return on assets−14.1 pts
−144.8%
2023 · hover or tap a bar for each year
20142023
Free cash flow margin−443.4 pts
−671.9%
2023 · hover or tap a bar for each year
20142023
Asset turnover−55.8%
0.21
2023 · hover or tap a bar for each year
20142023
TTOO financial health Debt, liquidity and how easily interest is covered.
Net debt−$15.1M
$33.8M
2023 · hover or tap a bar for each year
20142023
Current ratio−76.6%
0.45
2023 · hover or tap a bar for each year
20142023
Interest coverage
-9.3
2023 · hover or tap a bar for each year
20142023
Debt / assets−17.4%
1.42
2023 · hover or tap a bar for each year
20142023
TTOO efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding+31 days
91 days
2023 · hover or tap a bar for each year
20142023
Days of inventory+38 days
109 days
2023 · hover or tap a bar for each year
20142023
Days payables outstanding−2 days
34 days
2023 · hover or tap a bar for each year
20142023
Cash conversion cycle+71 days
166 days
2023 · hover or tap a bar for each year
20142023
Capex / revenue+1.1 pts
2.7%
2023 · hover or tap a bar for each year
20142023
TTOO returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
TTOO debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
TTOO cash returned to shareholders
DividendsBuybacksFree cash flow
TTOO key metrics
2014–2023| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns & profitability | ||||||||||
| Return on equity (ROE) | — | — | — | — | — | −803.9% | −306.9% | −127.0% | −90.6% | — |
| Return on invested capital (ROIC) | −534.1% | −386.4% | −185.3% | −281.7% | — | — | −856.2% | −616.9% | — | — |
| Return on assets (ROA) | −144.8% | −130.6% | −70.5% | −87.0% | −127.2% | −85.8% | −86.4% | −62.1% | −54.6% | −56.7% |
| Return on tangible assets | −143.9% | −180.3% | −81.3% | −59.2% | −207.1% | −79.5% | −113.8% | −61.2% | −52.1% | −39.8% |
| Free cash flow margin | −671.9% | −228.5% | −140.2% | −242.8% | −553.4% | −387.9% | — | — | — | — |
| Financial health | ||||||||||
| Total debt | $49.5M | $59.2M | $58.3M | $56.9M | $44.8M | $43.1M | $42.7M | $41.9M | $32.0M | $21.0M |
| Cash & short-term investments | $15.7M | $10.3M | $32.2M | $42.2M | $11.0M | $50.8M | $41.8M | $73.5M | $73.7M | $73.8M |
| Net debt | $33.8M | $48.9M | $26.1M | $14.7M | $33.7M | −$7.7M | $882,000 | −$31.6M | −$41.6M | −$52.9M |
| Debt / equity | — | — | — | 6.52 | — | 3.79 | 31.85 | 1.06 | 0.68 | 0.40 |
| Debt / assets | 1.42 | 1.72 | 0.96 | 0.72 | 1.57 | 0.67 | 0.78 | 0.47 | 0.37 | 0.27 |
| Current ratio | 0.45 | 1.92 | 3.80 | 5.47 | 0.31 | 1.08 | 0.86 | 7.63 | 6.16 | 15.50 |
| Quick ratio | 0.36 | 1.49 | 3.46 | 5.10 | 0.25 | 1.03 | 0.83 | 7.55 | 6.10 | 15.48 |
| Interest coverage | -9.3 | -8.9 | -5.7 | -7.5 | -7.1 | -6.7 | -6.0 | -12.4 | -22.1 | -42.6 |
| Working capital | −$31.0M | $9.3M | $32.7M | $43.8M | −$41.7M | $4.3M | −$7.5M | $65.6M | $63.3M | $70.5M |
| Invested capital | $5.8M | $8.9M | $13.2M | $23.5M | −$263,000 | $3.7M | $2.2M | $7.7M | $5.3M | $107,000 |
| Tangible asset value | −$28.0M | −$40.0M | −$12.9M | $8.7M | −$34.0M | $11.4M | $1.3M | $39.3M | $46.9M | $53.0M |
| Net current asset value | −$37.6M | −$54.9M | −$29.0M | −$16.8M | −$43.6M | $3.7M | −$9.2M | $25.2M | $35.6M | $49.5M |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | $0 | $0 | $0 | $0 |
| Share buybacks (net) | $0 | $330,000 | $0 | — | $0 | $0 | $0 | $0 | $0 | $0 |
| Capex / revenue | 2.7% | 1.5% | 1.6% | 4.4% | 9.1% | 5.6% | 53.1% | 134.5% | 283.5% | 1,751.3% |
| Capex / depreciation | 0.22 | 0.32 | 0.18 | 0.25 | 0.21 | 0.24 | 0.84 | 2.41 | 5.44 | 3.02 |
| Stock-based compensation / revenue | 60.5% | 29.1% | 25.3% | 21.6% | 65.5% | 94.3% | 102.7% | 118.8% | 148.2% | 1,389.1% |
| R&D / revenue | 196.8% | 116.3% | 77.7% | 93.3% | 195.9% | 138.0% | 508.6% | 588.5% | 901.6% | 16,623.5% |
| SG&A / revenue | 363.3% | 137.8% | 101.7% | 117.4% | 327.6% | 244.7% | 487.7% | 590.1% | 678.8% | 9,258.8% |
| Efficiency | ||||||||||
| Days sales outstanding | 90.9 | 59.7 | 66.6 | 79.8 | 101.0 | 39.2 | 31.1 | 31.1 | 37.0 | 616.5 |
| Days of inventory on hand | 108.9 | 71.3 | 66.5 | 62.0 | 68.3 | 47.6 | 32.6 | 39.5 | 83.7 | 2.1 |
| Days payables outstanding | 33.5 | 35.6 | 43.1 | 49.8 | 49.0 | 16.5 | 24.4 | 58.2 | 205.9 | 15.5 |
| Cash conversion cycle (days) | 166.3 | 95.4 | 90.0 | 92.0 | 120.3 | 70.3 | 39.2 | 12.4 | -85.2 | 603.2 |
| Receivables turnover | 4.02 | 6.11 | 5.48 | 4.58 | 3.62 | 9.32 | 11.75 | 11.72 | 9.87 | 0.59 |
| Payables turnover | 10.88 | 10.24 | 8.47 | 7.32 | 7.46 | 22.13 | 14.94 | 6.28 | 1.77 | 23.58 |
| Inventory turnover | 3.35 | 5.12 | 5.49 | 5.88 | 5.34 | 7.66 | 11.20 | 9.25 | 4.36 | 172.02 |
| Asset turnover | 0.21 | 0.47 | 0.40 | 0.34 | 0.18 | 0.18 | 0.06 | 0.05 | 0.03 | 0.00 |
| Average receivables | $1.8M | $3.6M | $5.1M | $4.0M | $2.3M | $1.1M | $397,000 | $348,000 | $285,000 | $201,000 |
| Average payables | $1.4M | $2.1M | $2.4M | $2.9M | $2.2M | $696,000 | $805,000 | $1.1M | $981,500 | $839,000 |
| Average inventory | $4.6M | $4.1M | $3.8M | $3.6M | $3.1M | $2.0M | $1.1M | $743,000 | $399,000 | $115,000 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from TTOO's annual financial statements (latest annual report filed April 1, 2024) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
TTOO valuation and financial ratios
T2 Biosystems earned a return on invested capital of −534.1% in fiscal 2023. It ended the year with $49.5 million of debt and $15.7 million in cash and short-term investments, net debt of $33.8 million.
See the TTOO income statement, the TTOO chart for price history, or the TTOO stock overview for the latest quote and news.
TTOO key metrics FAQ
What is T2 Biosystems's ROIC?
T2 Biosystems's return on invested capital was −534.1% in fiscal 2023, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does T2 Biosystems have?
T2 Biosystems had total debt of $49.5 million at the end of fiscal 2023.
What is T2 Biosystems's current ratio?
T2 Biosystems's current ratio was 0.45 at the end of fiscal 2023: current assets were 0.45 times current liabilities.